https://orcid.org/0000-0002-9183-4128
References
- Dutkiewicz J, Sroka J, Zajac V, et al. Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I – Epidemiology. Ann Agric Environ Med. 2017;24(4):683–95.
- WHO. World Health Organization http://www.who.int/en/.
- Gottschalk M, Xu J, Calzas C, et al. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 2010;5(3):371–91. doi:10.2217/fmb.10.2
- Gottschalk M, Segura M, Xu J. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev. 2007;8(1):29–45. doi:10.1017/S1466252307001247
- Vecht U, Wisselink HJ, van Dijk JE, et al. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun. 1992;60(2):550–6.
- Peixi Chang WL, Guolin Shi, Huan Li, et al. The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses. Virulence. 2018;
- Casino P, Rubio V, Marina A. Structural insight into partner specificity and phosphoryl transfer in two-component signal transduction. Cell. 2009;139(2):325–36. doi:10.1016/j.cell.2009.08.032
- Beier D, Gross R. Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol. 2006;9(2):143–52. doi:10.1016/j.mib.2006.01.005
- Bem AE, Velikova N, Pellicer MT, et al. Bacterial histidine kinases as novel antibacterial drug targets. ACS Chem Biol. 2015;10(1):213–24. doi:10.1021/cb5007135
- Tiwari S, Jamal SB, Hassan SS, et al. Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview. Frontiers in microbiology. 2017;8:1878. doi:10.3389/fmicb.2017.01878
- Velikova N, Fulle S, Manso AS, et al. Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens. 2016;6:26085.
- Dickey SW, Cheung GYC, Otto M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017;16(7):457–71. doi:10.1038/nrd.2017.23
- Wisselink HJ, Smith HE, Stockhofe-Zurwieden N, et al. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Veterinary microbiology. 2000;74(3):237–48. doi:10.1016/S0378-1135(00)00188-7
- Velikova N, Kavanagh K, Wells JM. Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis. BMC Microbiol. 2016;16(1):291. doi:10.1186/s12866-016-0905-2
- Zaccaria E, Cao R, Wells JM, et al. A Zebrafish Larval Model to Assess Virulence of Porcine Streptococcus suis Strains. PloS One. 2016;11(3):e0151623. doi:10.1371/journal.pone.0151623
- Winkler ME, Hoch JA. Essentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in gram-positive bacteria. J Bacteriol. 2008;190(8):2645–8. doi:10.1128/JB.01682-07
- Velikova N, Bem AE, van Baarlen P, et al. WalK, the Path towards New Antibacterials with Low Potential for Resistance Development. ACS Med Chem Lett. 2013;4(10):891–4. doi:10.1021/ml400320s